Atea Pharmaceuticals

Atea Pharmaceuticals is a company listed under the stock ticker AVIR (US).

View the org chart displaying its 23 main executives

Most searched biographies at Atea Pharmaceuticals

• Jean-Pierre Sommadossi, Chairman of the Board and Chief Executive ...
• Jerome Adams, Director
• Bruno Lucidi, Director

Popular executive movements at Atea Pharmaceuticals

• Nancy Agrawal has joined the company as Executive Vice President of Preclinical Development  (posted on February 11 2022).

Create an alert
to follow the executive moves at Atea Pharmaceuticals.

Atea Pharmaceuticals has 1,993 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Syros Pharmaceuticals has just announced a $190 Million fundraising. (posted on July 5 2022).
• Syros Pharmaceuticals has announced the acquisition of Tyme Technologies  (posted on July 5 2022).
• Regeneron Pharmaceuticals has announced the acquisition of Checkmate Pharmaceuticals  (posted on May 31 2022).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Director at Johnson & Johnson
• Richard Gonzalez - Chairman and Chief Executive Officer at AbbVie
• Keith Goldan - Chief Financial Officer at Syndax Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Atea Pharmaceuticals

• News Releases | Atea Pharmaceuticals, Inc.
• News | Atea Pharmaceuticals
• News | Atea Pharmaceuticals

Social media about Atea Pharmaceuticals

• Atea Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Atea Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Jean-Pierre Sommadossi

Call Atea Pharmaceuticals at +1 85...

View the org chart

Register to receive your alert

Report an error